Lukas Wettstein

9PUBLICATIONS
53CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsVeterinary virologyMolecular targetsBiomolecular modelling and designGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 14, 2025
Trypstatin as a Novel TMPRSS2 Inhibitor with Broad-Spectrum Efficacy against Corona and Influenza Viruses.

Jan Lawrenz, Lukas Wettstein, Armando Rodríguez Alfonso

|Sep 03, 2022
Native and activated antithrombin inhibits TMPRSS2 activity and SARS-CoV-2 infection.

Lukas Wettstein, Patrick Immenschuh, Tatjana Weil

|Jul 08, 2022
Peptidomimetic inhibitors of TMPRSS2 block SARS-CoV-2 infection in cell culture.

Lukas Wettstein, Philip Maximilian Knaff, Christian Kersten

|Feb 15, 2022
The Transmembrane Protease TMPRSS2 as a Therapeutic Target for COVID-19 Treatment.

Lukas Wettstein, Frank Kirchhoff, Jan Münch

|Jul 29, 2021
IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro.

Caterina Prelli Bozzo, Rayhane Nchioua, Meta Volcic

Pageof 2